News headlines about Dynatronics (NASDAQ:DYNT) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Dynatronics earned a media sentiment score of 0.10 on Accern’s scale. Accern also assigned media headlines about the medical equipment provider an impact score of 45.4125925076923 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Dynatronics (NASDAQ DYNT) traded down $0.35 on Friday, hitting $2.90. The stock had a trading volume of 62,416 shares, compared to its average volume of 17,737. Dynatronics has a 12 month low of $2.10 and a 12 month high of $3.75. The company has a quick ratio of 0.92, a current ratio of 1.46 and a debt-to-equity ratio of 0.81. The firm has a market capitalization of $15.99, a P/E ratio of -2.61 and a beta of -0.14.

Dynatronics (NASDAQ:DYNT) last posted its earnings results on Tuesday, November 14th. The medical equipment provider reported $0.00 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.08) by $0.08. Dynatronics had a negative return on equity of 45.78% and a negative net margin of 3.42%. The company had revenue of $12.80 million during the quarter. sell-side analysts expect that Dynatronics will post -0.09 EPS for the current year.

Separately, Zacks Investment Research downgraded Dynatronics from a “buy” rating to a “hold” rating in a report on Friday, January 12th.

In related news, major shareholder Stuart Essig purchased 27,455 shares of the company’s stock in a transaction that occurred on Wednesday, January 3rd. The stock was acquired at an average price of $2.77 per share, with a total value of $76,050.35. Following the completion of the purchase, the insider now directly owns 856,169 shares in the company, valued at $2,371,588.13. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Brian Larkin purchased 40,000 shares of the company’s stock in a transaction that occurred on Thursday, November 30th. The stock was bought at an average cost of $2.50 per share, with a total value of $100,000.00. Following the purchase, the director now owns 80,276 shares of the company’s stock, valued at $200,690. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 369,015 shares of company stock valued at $930,372. 51.80% of the stock is owned by insiders.

ILLEGAL ACTIVITY WARNING: “Somewhat Positive Media Coverage Somewhat Unlikely to Affect Dynatronics (DYNT) Stock Price” was first published by Daily Political and is owned by of Daily Political. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at

About Dynatronics

Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals.

Insider Buying and Selling by Quarter for Dynatronics (NASDAQ:DYNT)

Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with's FREE daily email newsletter.